Agilent Technologies

Agilent Technologies Current Liabilities

The Current Liabilities of Agilent Technologies (A) as of Nov 7, 2026 is 2.73 B USD. In the previous year, Current Liabilities was 1.97 B USD — a change of 39.08% (higher).

Current Liabilities

2.73 BUSD

YoY

39.08%

Last updated:

Current Liabilities of Agilent Technologies is 2025 2.73 B USD. Current Liabilities of Agilent Technologies was 2024 1.97 B USD. It decreases by 39.08% higher compared to the previous year.

The Agilent Technologies Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
1.35 B USD
Jan 1, 2019
2.51 B USD
Jan 1, 2020
1.73 B USD
Jan 1, 2021
2.09 B USD
Jan 1, 2022
2.18 B USD
Jan 1, 2023
1.71 B USD
Jan 1, 2024
1.97 B USD
Jan 1, 2025
2.73 B USD
The Agilent Technologies Current Liabilities history
YEARCurrent LiabilitiesYoY
2.73 BUSD+39.08%
1.97 BUSD+15.25%
1.71 BUSD-21.93%
2.18 BUSD+4.60%
2.09 BUSD+20.48%
1.73 BUSD-31.04%
2.51 BUSD+86.29%
1.35 BUSD-11.42%
1.52 BUSD+39.98%
1.09 BUSD-6.37%
1.16 BUSD-36.19%
1.82 BUSD-3.55%
1.89 BUSD-23.84%
2.48 BUSD+2.27%
2.42 BUSD-51.04%
4.95 BUSD+268.65%
1.34 BUSD-19.05%
1.66 BUSD-16.34%
1.98 BUSD+6.73%
1.86 BUSD-28.26%
2.59 BUSD+11.78%
2.32 BUSD-8.09%
2.52 BUSD-13.01%
2.90 BUSD+0.59%
2.88 BUSD-22.45%
3.72 BUSD+56.75%
2.37 BUSD-7.35%
2.56 BUSD+67.96%
1.52 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Agilent Technologies Stock analysis

What does Agilent Technologies do? Agilent Technologies Inc. is a global technology company that operates in the fields of life science, diagnostics, and applied chemistry. The company is headquartered in Santa Clara, California and employs over 16,000 people worldwide. History: Agilent was founded in 1999 as a spin-off from Hewlett-Packard and became an independent company in 2014. Agilent's success is built on the strong research and development tradition of Hewlett-Packard, particularly in the field of measurement and testing technology. Since its inception, Agilent has developed a strong culture of innovation and is now a leader in the field of life science and diagnostics technologies. Business model: Agilent's business model is based on delivering innovative technologies and services for the life science, diagnostics, and applied chemistry industries. Agilent offers a wide range of products such as chromatography systems, mass spectrometers, real-time PCR systems, spectroscopy systems, and genotyping services. The company adopts a customer-oriented approach and works closely with its customers to develop tailored products and services that meet their specific needs. Divisions: Agilent is divided into four divisions: 1. Life Sciences and Applied Chemistry: This division includes products and services for bioscientific research and applied chemistry, including chromatography systems, mass spectrometers, spectroscopy systems, and gas chromatographs. 2. Diagnostics and Genomics: This division specializes in the development and manufacturing of diagnostic products and services for the clinical laboratory sector, including real-time PCR systems, genotyping services, and products for cancer and infectious diseases. 3. Agilent CrossLab: This division offers a wide range of laboratory services and solutions, including chemistry, polymer, and refractometer products, as well as instrument maintenance and repair. 4. Electronics and Communications: This division includes products and solutions for electronic measurement and communication measurement industries. Products include oscilloscopes, signal generators, network analyzers, and spectrum analyzers. Products: Agilent offers a wide range of products to support research, diagnostics, and plasmid production in the life sciences industry. Some of the well-known products include: 1. Chromatography systems: Agilent offers various types of chromatography systems such as HPLC systems, GC systems, and LC/MS systems, which are used for separation, purification, and analysis of compounds. 2. Mass spectrometers: The company produces various mass spectrometer systems such as high-resolution mass spectrometers, triple quadrupole mass spectrometers, and liquid chromatography-mass spectrometers, which are used for identification and quantification of compounds. 3. Real-time PCR systems: Agilent offers a wide range of real-time PCR systems that enable the quantification of nucleic acid sequences in real time. 4. Spectroscopy systems: The company produces various spectroscopy systems such as UV-Vis spectrometers, infrared spectrometers, and atomic absorption spectrometers, which are used for identification and quantification of compounds in many industry segments. Conclusion: Agilent is a leading technology company in the fields of life science, diagnostics, and applied chemistry. The company has a reputation as an innovator and market leader in the industry, based on its strong research and development tradition and clear customer orientation. Agilent Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Agilent Technologies stock

Current Liabilities of Agilent Technologies is 2.73 B USD in 2025.

Current Liabilities of Agilent Technologies changed from 1.97 B USD to 2.73 B USD, representing a 39.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Agilent Technologies since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Agilent Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Agilent Technologies

All Key Metrics — Agilent Technologies